Advantages of VMAT-IMRT technique in nasopharyngeal cancer

Open access


BACKGROUND. Radiotherapy, associated with chemotherapy, is the main method of treatment in both early and advanced stages of nasopharyngeal carcinoma. Intensity modulated radiation therapy (IMRT) provides high doses of radiation to the primary tumor, sparing the organs at risk. Volumetric modulated arc therapy (VMAT) is one of the most promising radiation methods which produces superior target coverage, improving the protection of organs at risk and reduces treatment time.

MATERIAL AND METHODS. We performed a retrospective study on 30 patients diagnosed with nasopharyngeal cancer and admitted in “Sfanta Maria” Clinical Hospital between October 2012 and December 2014. All patients have undergone VMAT-IMRT associated with induction or concurrent chemotherapy. At the end of the treatment, patients were followed up at one, three and six months, and then every six months for 2 years.

RESULTS. At the end of the radio-chemotherapy treatment, 27 patients (90%) had a complete tumor and lymphatic response and 3 of them (10%) presented a partial response. At the end of the follow-up period, we observed 5 patients with recurrences, including 2 deceased.

CONCLUSION. VMAT-IMRT in association with chemotherapy treatment is well tolerated by patients. The good results reflected in high rates of cured patients, the low incidence of side effects, recommend this treatment plan as an optimal indication for nasopharyngeal tumors.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • 1. Ma j. Cao S. – The epidemiology of nasopharyngeal carcinoma. In: Lu J.J. Cooper J.S. Lee A.W.M. (Eds.) - Nasopharyngeal Cancer: Multidisciplinary Management. Springer-Verlag Berlin Heidelberg 2010;p.1-8.

  • 2. Parkin D.M. Whelan S.L. Ferlay J. Raymond L. Young J. editors. - Cancer incidence in five continents. Volume VII. IARC 1997;Sci Publ no. 143.

  • 3. Marks J.E. Phillips J.L. Menck H.R. - The National Cancer Data Base report on the relationship of race and national origin to the histology of nasopharyngeal carcinoma. Cancer 1998;83(3):582–588.

  • 4. Cheng J.C. Chao K.S. Low D. - Comparison of intensity modulated radiation therapy (IMRT) treatment techniques for nasopharyngeal carcinoma. Int J Cancer 2001;96(2):126–131.

  • 5. Kam M.K. Chau R.M. Suen J. Choi P.H. Teo P.M. - Intensity-modulated radiotherapy in nasopharyngeal carcinoma: Dosimetric advantage over conventional plans and feasibility of dose escalation. Int J Radiat Onc Biol Phys. 2003;56(1):145–157.

  • 6. Xia P. Fu K.K. Wong G.W. Akazawa C. Verhey L.J. - Comparison of treatment plans involving intensity-modulated radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2000;48(2):329–337.

  • 7. Otto K. - Volumetric modulated arc therapy: IMRT in a single gantry arc. Med Phys. 2008;35(1):310-317.

  • 8. Zhao N. Yang R. Jiang Y. Tian S. Guo F. Wang J. - A Hybrid IMRT/VMAT Technique for the Treatment of Nasopharyngeal Cancer. BioMed Research International 2015;(2015). Article ID 940102.

  • 9. Verbakel W.F. Cuijpers J.P. Hoffmans D. Bieker M. Slotman B.J. Senan S. - Volumetric intensity-modulated arc therapy vs. conventional IMRT in head-and-neck cancer: a Comparative Planning and Dosimetric Study. Int J Radiat Oncol Biol Phys. 2009;74(1):252–259. doi: 10.1016/j.ijrobp.2008.12.033.

  • 10. Zhao N. Yang R. Wang J. - A Novel Integrated VMAT/IMRT Technique for the Treatment of Nasopharyngeal Carcinoma. Int J Radiat Oncol Biol Phys. 2014;90(1 Suppl):S937-S938.

  • 11. Kwong D. McMillan A. Pow E. Sham J. - A randomized trial comparing intensity modulated radiotherapy versus 2-dimensional radiotherapy for stage II nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2008;72(1 Suppl):S98.

  • 12. Lee A.W. Law S.C. Ng S.H. Chan D.K. Poon Y.F. Foo W. Tung S.Y. Cheung F.K. Ho J.H. - Retrospective analysis of nasopharyngeal carcinoma treated during 1976–1985: late complications following megavoltage irradiation. Br J Radiol. 1992;65(778):918–928.

  • 13. Kristensen C.A. Kjær-Kristoffersen F. Sapru W. Berthelsen A.K. Loft A. Specht L. - Nasopharyngeal carcinoma. Treatment planning with IMRT and 3D conformal radiotherapy. Acta Oncol. 2007;46(2):214-220.

  • 14. Langendijk J.A. Leemans C.R. Buter J. Berghof J. Slotman B.J. - The additional value of chemotherapy to radiotherapy in locally advanced nasopharyngeal carcinoma: A meta-analysis of the published literature. J Clin Oncol. 2004;22(22):4604-4612.

  • 15. Lee N. Xia P. Quivey J.M. Sultanem K. Poon I. Akazawa C. Akazawa P. Weinberg V. Fu K.K. - Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys. 2002;53(1):12–22.

  • 16. Kim J.W. Cho J.H. Keum K.C. Kim J.H. Kim G.E. Lee J.Y. Kim S.K. Lee C.G. - IMRT with Simultaneous Integrated Boost and Concurrent Chemotherapy for Nasopharyngeal Cancer: Plan Evaluation and Treatment Outcome. Jpn J Clin Oncol. 2012;42(12):1152-1160. doi: 10.1093/jjco/hys169. Epub 2012 Oct 16.

  • 17. Guo R. Tang L.L. Mao Y.P. Zhou G.Q. Qi Z.Y. Liu L.Z. Lin A.H. Liu M.Z. Ma J. Sun Y. - Clinical Outcomes of Volume-Modulated Arc Therapy in 205 Patients with Nasopharyngeal Carcinoma: An Analysis of Survival and Treatment Toxicities. PLoS One 2015;10(7):e0129679. doi: 10.1371/journal.pone.0129679. eCollection 2015.

  • 18. Saleh-Ebrahimi L. Zwicker F. Muenter. Marc W. Bischof M. Lindel K. Debus J. Huber P.E. Roeder F. – Intensity modulated radiotherapy (IMRT) combined with concurrent but not adjuvant chemotherapy in primary nasopharyngeal cancer - a retrospective single center analysis. Radiation Oncology 2013;8:20. doi: 10.1186/1748-717x-8-20.

Journal information
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 277 70 4
PDF Downloads 121 49 5